A. Menarini Industrie Farmaceutiche Riunite s.r.l.
EU Lobbying Profiles
A. Menarini Industrie Farmaceutiche Riunite s.r.l.
Register: EU_TRANSPARENCY_REGISTER
Declared Spend (Max)
€199,999
Regulatory Meetings
Life Sciences Roundtable
Challenges and priorities for health and life sciences
EU initiatives in the field of pharmaceutical sector
Challenges and priorities for health and life sciences
EU initiatives in the field of pharmaceutical sector
Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation
Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation
Menarini, a €3 billion revenue pharmaceutical manufacturer, mostly active in the generic medicines domain, wanted to discuss the recently adopted Commission proposal for a Critical Medicines Act (CMA), and provide some first reactions.
Government Procurement
No government procurement contracts found.
Executive Insider Trades
No executive insider trades reported.